Category: Private Citizen — Corporate Director Role: Independent Director, UnitedHealth Group Inc. (UNH); Audit and Finance Committee Chair Board Tenure: 2018 – present Committee Memberships: Audit and Finance Committee (Chair); Governance Committee Profile Type: Board Member Accountability — Anchor B (Documented Organizational Leadership)

Basis for Inclusion: F. William McNabb III holds a documented governance role as Audit and Finance Committee Chair at UnitedHealth Group Inc., which made documented political donations to Trump-aligned entities while facing antitrust scrutiny. As Audit Committee Chair, McNabb holds primary board-level oversight responsibility for UnitedHealth’s financial reporting and internal controls — including the financial impact of the Change Healthcare data breach. This profile documents the factual governance relationship, not the subject’s personal political views.

Subject Classification: Private Citizen / Corporate Director. Board membership is a matter of public record (SEC filings, proxy statements). This profile documents only the governance role and its connection to documented corporate political activity.

Biographical Overview

F. William “Bill” McNabb III served as Chairman and CEO of The Vanguard Group from 2008 to 2018 (CEO) and 2010 to 2019 (Chairman), leading one of the world’s largest investment management companies — a major institutional shareholder of UnitedHealth Group and virtually every large U.S. public company. He joined Vanguard in 1986 and held progressive leadership roles across institutional, retail, and international businesses. Under his leadership, Vanguard’s assets grew from approximately $1 trillion to more than $5 trillion.

McNabb’s background as CEO of one of the world’s largest index fund managers makes him one of the most credentialed financial oversight voices in corporate governance. His role chairing UnitedHealth’s Audit and Finance Committee means he has primary board responsibility for the financial integrity reporting on a company with over $360 billion in annual revenue.

He holds a B.A. in History from Dartmouth College and an MBA from the University of Pennsylvania’s Wharton School.

Board Role and Governance Authority

• Company: UnitedHealth Group Inc. (NYSE: UNH)
• Board tenure: 2018 – present
• Committee assignments: Audit and Finance Committee (Chair); Governance Committee

Parent Corporate Donor Profile

This profile is a governance-accountability companion to the UnitedHealth Group corporate donor profile, which documents the corporation’s political spending and regulatory relationships under the Trump administration.

Factual correction requests: If you believe information in this profile is incorrect, please contact factcheck@citizenanalyst.ai with your name (optional), the specific claim, and any supporting documentation. We review all submissions and correct verified errors promptly.

Investigative trail pointers (public records)

Education only — verify independently. Absence of hits is not proof.

Use public-records-research-specialist, corporate-intelligence-investigator, and public-corruption-ombudsman evidence tiers.

Sources

• UnitedHealth Group Inc. DEF 14A Proxy Statement, filed April 21, 2025; SEC EDGAR (CIK 731766)